{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T12:21:46Z","timestamp":1769775706186,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005342","name":"Foundation of Friends of Beatrix Children's Hospital","doi-asserted-by":"publisher","award":["StBKZ.2012"],"award-info":[{"award-number":["StBKZ.2012"]}],"id":[{"id":"10.13039\/501100005342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ymgme.2025.109263","type":"journal-article","created":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T22:07:41Z","timestamp":1760306861000},"page":"109263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseases"],"prefix":"10.1016","volume":"146","author":[{"given":"Ruben J.","family":"Overduin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candelas","family":"Gross-Valle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost","family":"Groen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"van der Krogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa A.","family":"Koops","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry G.J.","family":"Derks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Rebecca","family":"Heiner-Fokkema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea B.","family":"Haijer-Schreuder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pcl.2017.11.005","article-title":"Inborn errors of metabolism with hypoglycemia: glycogen storage diseases and inherited disorders of gluconeogenesis","volume":"65","author":"Weinstein","year":"2018","journal-title":"Pediatr. Clin. N. Am."},{"issue":"0","key":"10.1016\/j.ymgme.2025.109263_bb0010","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1007\/BF02680007","article-title":"Guidelines for management of glycogen storage disease type I - European study on glycogen storage disease type I (ESGSD I)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr."},{"issue":"0","key":"10.1016\/j.ymgme.2025.109263_bb0015","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1007\/s00431-002-1017-6","article-title":"Consensus guidelines for management of glycogen storage disease type 1b - European study on glycogen storage disease type 1","volume":"161","author":"Visser","year":"2002","journal-title":"Eur. J. Pediatr."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109263_bb0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41436-018-0364-2","article-title":"Diagnosis and management of glycogen storage diseases type VI and IX: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"21","author":"Kishnani","year":"2019","journal-title":"Genet. Med."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109263_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109263_bb0030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2025.109263_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107525","article-title":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: a clinical practice resource","volume":"138","author":"Koch","year":"2023","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0040","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/bms.1200030202","article-title":"Quantitation of a urinary tetrasaccharide by gas chromatography and mass spectrometry","volume":"3","author":"Lennartson","year":"1976","journal-title":"Biomed. Mass Spectrom."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109263_bb0045","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s10545-005-0095-9","article-title":"Biochemical characteristics and increased tetraglucoside excretion in patients with phosphorylase kinase deficiency","volume":"28","author":"Morava","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0050","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10545-011-9360-2","article-title":"Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases","volume":"35","author":"Manwaring","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0055","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1006\/abio.2000.4838","article-title":"Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of pompe disease","volume":"287","author":"An","year":"2000","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.ymgme.2025.109263_bb0060","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1373\/clinchem.2011.178319","article-title":"Rapid ultraperformance liquid chromatography-tandem mass spectrometry assay for a characteristic glycogen-derived tetrasaccharide in pompe disease and other glycogen storage diseases","volume":"58","author":"Sluiter","year":"2012","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-5793(79)80095-2","article-title":"Increased urinary excretion of a glucose-containing tetrasaccharide in patients with duchenne muscular dystrophy","volume":"97","author":"Lundblad","year":"1979","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0009-8981(88)90172-6","article-title":"Urinary excretion of a glucose-containing tetrasaccharide. A parameter for increased degradation of glycogen","volume":"176","author":"Kumlien","year":"1988","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0003-2697(89)90716-1","article-title":"Analysis of a glucose-containing tetrasaccharide by high-performance liquid affinity chromatography","volume":"182","author":"Wang","year":"1989","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0080","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-1759(82)90215-0","article-title":"Determination of a glucose-containing tetrasaccharide in urine by radioimmunoassay","volume":"48","author":"Zopf","year":"1982","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.ymgme.2025.109263_bb0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0021-9258(19)75202-8","article-title":"Quantitation of some urinary oligosaccharides during pregnancy and lactation","volume":"252","author":"Hallgren","year":"1977","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0090","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1042\/bj0760246","article-title":"The mechanism of carbohydrase action. 5. Action of human salivary alpha-amylase on amylopectin and glycogen","volume":"76","author":"Roberts","year":"1960","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0095","first-page":"27","article-title":"Studies on the metabolic origin of a glucose-containing tetrasaccharide in human urine","volume":"1","author":"Ugorski","year":"1983","journal-title":"J. Exp. Pathol."},{"issue":"5","key":"10.1016\/j.ymgme.2025.109263_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0105","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/ajmg.c.31320","article-title":"Assessing disease severity in Pompe disease: the roles of a urinary glucose tetrasaccharide biomarker and imaging techniques","volume":"160C","author":"Young","year":"2012","journal-title":"Am. J. Med. Genet. C: Semin. Med. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2025.109263_bb0110","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ymgme.2005.03.010","article-title":"Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease","volume":"85","author":"An","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0115","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jimd.12178","article-title":"Research priorities for liver glycogen storage disease: An international priority setting partnership with the James Lind Alliance","volume":"43","author":"Peeks","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.ymgme.2025.109263_bb0120","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1172\/JCI118799","article-title":"Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle","volume":"98","author":"Shen","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymgme.2025.109263_bb0125","article-title":"The relation between dietary polysaccharide intake and urinary excretion of tetraglucoside","author":"Gross-Valle","year":"2024","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2025.109263_bb0130","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41436-020-0878-2","article-title":"The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases","volume":"22","author":"Heiner-Fokkema","year":"2020","journal-title":"Genet. Med."},{"issue":"8331","key":"10.1016\/j.ymgme.2025.109263_bb0135","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0140-6736(83)92122-0","article-title":"Increased urinary excretion of a glycogen-derived tetrasaccharide in heterozygotes with glycogen storage diseases type II and III","volume":"1","author":"Alan Chester","year":"1983","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ymgme.2025.109263_bb0140","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/clinchem\/36.7.1381a","article-title":"Unique oligosaccharide (apparently glucotetrasaccharide) in urine of patients with glycogen storage diseases","volume":"36","author":"Oberholzer","year":"1990","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ymgme.2025.109263_bb0145","article-title":"Urine glucose tetrasaccharide: a good biomarker for glycogenoses type II and III? A study of the French cohort","volume":"23","author":"Piraud","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ymgme.2025.109263_bb0150","first-page":"39","article-title":"Utility of a urinary tetrasaccharide as a biomarker for glycogen storage disease type III","volume":"98","author":"Tolun","year":"2009","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2025.109263_bb0155","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41436-019-0561-7","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring","volume":"21","author":"Halaby","year":"2019","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0160","first-page":"37","article-title":"Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III","volume":"58","author":"Young","year":"2020","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2025.109263_bb0165","series-title":"GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024","article-title":"Phosphorylase kinase deficiency","author":"Herbert","year":"2018"},{"issue":"1","key":"10.1016\/j.ymgme.2025.109263_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijns11010001","article-title":"Newborn screening by DNA-first: systematic evaluation of the eligibility of inherited metabolic disorders based on treatability","volume":"11","author":"Veldman","year":"2024","journal-title":"Int. J. Neonatal. Screen."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002550?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225002550?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T19:50:46Z","timestamp":1769716246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225002550"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1096719225002550"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109263","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary tetraglucoside excretion as a biomarker in liver glycogen storage diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109263","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109263"}}